Ideaya Biosciences (IDYA) Stock Price Target Increased by Mizuho

Mizuho raised the price target for Ideaya Biosciences (IDYA) following new trial data. The updated target reflects positive expectations for ongoing clinical trials. This change may influence investor sentiment and trading volumes as market participants react to the new data. Price targets are often considered by investors when assessing potential stock performance, impacting IDYA's market perception and valuation.